Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
24631 | 306 | 37.0 | 77% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
1 | 4 | ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL | 3876184 |
320 | 3 | AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION//MEDICATION ERRORS//AMERICAN JOURNAL OF HOSPITAL PHARMACY | 39312 |
1308 | 2 | MEDICATION ERRORS//POLYPHARMACY//MEDICATION RECONCILIATION | 8523 |
24631 | 1 | SERUM ANTICHOLINERGIC ACTIVITY//ANTICHOLINERGIC BURDEN//ANTICHOLINERGIC ACTIVITY | 306 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | SERUM ANTICHOLINERGIC ACTIVITY | authKW | 1124278 | 4% | 87% | 13 |
2 | ANTICHOLINERGIC BURDEN | authKW | 907164 | 3% | 91% | 10 |
3 | ANTICHOLINERGIC ACTIVITY | authKW | 814926 | 5% | 58% | 14 |
4 | DRUG BURDEN INDEX | authKW | 621752 | 3% | 69% | 9 |
5 | ANTICHOLINERGIC DRUGS | authKW | 432651 | 8% | 19% | 23 |
6 | ATROPINIC BURDEN | authKW | 399153 | 1% | 100% | 4 |
7 | ANTICHOLINERGICS | authKW | 214403 | 12% | 6% | 36 |
8 | ANTICHOLINERGIC AND SEDATIVE MEDICATIONS | authKW | 199577 | 1% | 100% | 2 |
9 | ANTICHOLINERGIC DRUG EXPOSURE | authKW | 199577 | 1% | 100% | 2 |
10 | ANTICHOLINERGIC DRUG SCALE | authKW | 199577 | 1% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Geriatrics & Gerontology | 18554 | 42% | 0% | 128 |
2 | Gerontology | 7174 | 20% | 0% | 61 |
3 | Psychiatry | 938 | 21% | 0% | 63 |
4 | Pharmacology & Pharmacy | 897 | 33% | 0% | 100 |
5 | Clinical Neurology | 143 | 11% | 0% | 33 |
6 | Medicine, General & Internal | 133 | 11% | 0% | 34 |
7 | Primary Health Care | 107 | 2% | 0% | 6 |
8 | Psychology | 39 | 3% | 0% | 9 |
9 | Psychology, Clinical | 38 | 3% | 0% | 9 |
10 | Neurosciences | 31 | 8% | 0% | 26 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EDUC AGEING CERA | 199577 | 1% | 100% | 2 |
2 | KUOPIO GERIATR CARE | 195212 | 5% | 13% | 15 |
3 | CLIN PSYCHOPHARM | 179617 | 1% | 60% | 3 |
4 | UNIT GEN INTERNAL MED GERIATR | 179617 | 1% | 60% | 3 |
5 | AGED CARE | 164763 | 6% | 10% | 17 |
6 | PHARMACEUT HLTH OUTCOMES POLICY | 163742 | 3% | 21% | 8 |
7 | KARASUYAMA HOSP | 138823 | 3% | 17% | 8 |
8 | CLIN PHARMACOL GERIATR PHARMACOTHER Y UNIT | 101855 | 2% | 15% | 7 |
9 | AGING EXCELLENCE COMMUNITY WELLNESS | 99788 | 0% | 100% | 1 |
10 | ARBEITSBEREICH ALTERSMED | 99788 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DRUGS & AGING | 31983 | 8% | 1% | 25 |
2 | AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY | 8862 | 1% | 2% | 4 |
3 | JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 8210 | 8% | 0% | 26 |
4 | NEURODEGENERATIVE DISEASES | 7093 | 2% | 1% | 7 |
5 | JOURNAL OF CLINICAL AND EXPERIMENTAL GERONTOLOGY | 6649 | 1% | 3% | 2 |
6 | AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY | 5007 | 3% | 1% | 10 |
7 | JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION | 3537 | 2% | 1% | 7 |
8 | JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION | 1942 | 1% | 0% | 4 |
9 | AGE AND AGEING | 1458 | 2% | 0% | 7 |
10 | JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 1319 | 2% | 0% | 6 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | COLLAMATI, A , MARTONE, AM , POSCIA, A , BRANDI, V , CELI, M , MARZETTI, E , CHERUBINI, A , LANDI, F , (2016) ANTICHOLINERGIC DRUGS AND NEGATIVE OUTCOMES IN THE OLDER POPULATION: FROM BIOLOGICAL PLAUSIBILITY TO CLINICAL EVIDENCE.AGING CLINICAL AND EXPERIMENTAL RESEARCH. VOL. 28. ISSUE 1. P. 25 -35 | 61 | 73% | 4 |
2 | SALAHUDEEN, MS , HILMER, SN , NISHTALA, PS , (2015) COMPARISON OF ANTICHOLINERGIC RISK SCALES AND ASSOCIATIONS WITH ADVERSE HEALTH OUTCOMES IN OLDER PEOPLE.JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. VOL. 63. ISSUE 1. P. 85 -90 | 46 | 85% | 15 |
3 | MAYER, T , HAEFELI, WE , SEIDLING, HM , (2015) DIFFERENT METHODS, DIFFERENT RESULTS-HOW DO AVAILABLE METHODS LINK A PATIENT'S ANTICHOLINERGIC LOAD WITH ADVERSE OUTCOMES?.EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 71. ISSUE 11. P. 1299 -1314 | 57 | 81% | 3 |
4 | SALAHUDEEN, MS , DUFFULL, SB , NISHTALA, PS , (2015) ANTICHOLINERGIC BURDEN QUANTIFIED BY ANTICHOLINERGIC RISK SCALES AND ADVERSE OUTCOMES IN OLDER PEOPLE: A SYSTEMATIC REVIEW.BMC GERIATRICS. VOL. 15. ISSUE . P. - | 46 | 85% | 12 |
5 | NISHTALA, PS , SALAHUDEEN, MS , HILMER, SN , (2016) ANTICHOLINERGICS: THEORETICAL AND CLINICAL OVERVIEW.EXPERT OPINION ON DRUG SAFETY. VOL. 15. ISSUE 6. P. 753 -768 | 68 | 55% | 0 |
6 | LOPEZ-ALVAREZ, J , SEVILLA, MAZ , ORTIZ, LA , BLAZQUEZ, MAF , SOLER, MV , MARTINEZ-MARTIN, P , (2015) EFFECT OF ANTICHOLINERGIC DRUGS ON COGNITIVE IMPAIRMENT IN THE ELDERLY.REVISTA DE PSIQUIATRIA Y SALUD MENTAL. VOL. 8. ISSUE 1. P. 35 -43 | 36 | 86% | 3 |
7 | SALAHUDEEN, MS , NISHTALA, PS , (2016) EXAMINATION AND ESTIMATION OF ANTICHOLINERGIC BURDEN: CURRENT TRENDS AND IMPLICATIONS FOR FUTURE RESEARCH.DRUGS & AGING. VOL. 33. ISSUE 5. P. 305 -313 | 49 | 60% | 1 |
8 | SALAHUDEEN, MS , CHYOU, TY , NISHTALA, PS , (2016) SERUM ANTICHOLINERGIC ACTIVITY AND COGNITIVE AND FUNCTIONAL ADVERSE OUTCOMES IN OLDER PEOPLE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE LITERATURE.PLOS ONE. VOL. 11. ISSUE 3. P. - | 42 | 75% | 0 |
9 | FOX, C , SMITH, T , MAIDMENT, I , CHAN, WY , BUA, N , MYINT, PK , BOUSTANI, M , KWOK, CS , GLOVER, M , KOOPMANS, I , ET AL (2014) EFFECT OF MEDICATIONS WITH ANTI-CHOLINERGIC PROPERTIES ON COGNITIVE FUNCTION, DELIRIUM, PHYSICAL FUNCTION AND MORTALITY: A SYSTEMATIC REVIEW.AGE AND AGEING. VOL. 43. ISSUE 5. P. 604 -615 | 34 | 71% | 23 |
10 | WOUTERS, H , VAN DER MEER, H , TAXIS, K , (2017) QUANTIFICATION OF ANTICHOLINERGIC AND SEDATIVE DRUG LOAD WITH THE DRUG BURDEN INDEX: A REVIEW OF OUTCOMES AND METHODOLOGICAL QUALITY OF STUDIES.EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 73. ISSUE 3. P. 257 -266 | 35 | 74% | 0 |
Classes with closest relation at Level 1 |